Objective: Hypogastric artery embolization (HAE) is associated with significant risk of ischemic complications. We assessed the impact of HAE on 30-day outcomes of endovascular aneurysm repair (EVAR) of infrarenal abdominal aortic aneurysms.
Successful outcomes of endovascular aneurysm repair (EVAR) of infrarenal abdominal aortic aneurysms are largely a product of favorable aneurysmal anatomy with proximal and distal landing zones permissive of sufficient endograft fixation and aneurysm sac exclusion. Approximately 15% to 40% of patients with abdominal aortic aneurysm have an associated aneurysm or ectasia of the iliac artery, creating unfavorable distal sealing zones. 1, 2 Endovascular treatment of such aneurysms is most commonly accomplished by coil embolization of the internal iliac artery followed by distal extension of the endograft limb to the external iliac artery. Unilateral embolization of the hypogastric artery with preservation of the contralateral artery is generally well tolerated because of substantial collateral pelvic flow. Pelvic ischemia complications, such as buttock claudication in 12% to 55% and erectile dysfunction in 1% to 13%, have been reported. 3 Colonic ischemia is a rare but often lethal complication after EVAR. 4 The reported risk of ischemic complications (specifically risk of ischemic colitis) after EVAR with hypogastric artery embolization (HAE) is highly variable. Some investigators have reported an increased risk of such complications, whereas others do not. [5] [6] [7] As a result, further data are needed on outcomes of EVAR with HAE. Continued advancement of endovascular techniques and endograft design has allowed preservation of hypogastric artery flow. Early studies with now commercially available branched iliac devices have reported lower ischemic complications. 8, 9 To this end, our objective was to use a The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
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METHODS
The American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) is a nationally validated, prospectively collected, preoperative through 30-day postoperative set of data variables on randomly assigned patients. 10 Beginning in 2011, the ACS NSQIP expanded the database to collect data on specific operative procedures and associated perioperative variables across certain subspecialties. We queried the ACS NSQIP vascular procedure-targeted Participant Use Data Files (PUF) from 2011 through 2014. All cases undergoing endovascular repair of aortic aneurysm were identified from the vascular procedure-targeted PUF.
The identified cases and associated target-specific variables were then merged with the main ACS NSQIP adult PUF. The data set contained a total of 7342 cases of endovascular repair of aortic aneurysms. Aortic aneurysms that underwent endovascular repair that were not classified as infrarenal or required hypogastric artery revascularization were excluded from the study. A total of 5881 cases of endovascular repair of infrarenal abdominal aortic aneurysms were subsequently identified. The cohort was divided into two groups based on whether they underwent an EVAR procedure only or concomitant EVAR and HAE. Clinical features, operative details, and 30-day outcomes of EVAR with and without HAE were examined. Data collected on reported variables are subject to definitions of the ACS NSQIP database. HAE was recorded as a dichotomous variable for occurrence of the procedure in the ACS NSQIP database. As a result, unilaterality or bilaterality of the procedure or occurrence of prior staged HAE cannot be determined. The primary end points were 30-day mortality and ischemic colitis. Secondary end points included length of stay, readmission rates, reoperations, transfusion requirements, pulmonary complications, postoperative renal failure, thromboembolic events, stroke, myocardial infarction, lower extremity ischemia, and discharge status. Categorical variables were compared using Fisher exact or Pearson c 2 tests as appropriate. Normally distributed continuous data were analyzed using unpaired Student t-test. Univariate analysis was performed to examine the relationship between each preoperative and intraoperative variable and significant postoperative complications and mortality. For each significant postoperative complication, a separate multivariable logistic regression model was developed using forward stepwise logistic regression analysis. For each model, all preoperative and intraoperative variables were considered with P # .05 for entry and P $ .10 for exit from the model. The variables age, American Society of Anesthesiologists (ASA) physical status classification, and operative time were dichotomized in the logistic regression models.
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Mean value for the sample was used to dichotomize age as >74 years compared with #74 years and operative time >143 minutes compared with #143 minutes. ASA physical status classification was dichotomized as class >3 compared with #3. The fit of the logistic model was examined using the HosmereLemeshow goodnessof-fit test. Adjusted odds ratios (ORs) are reported with 95% confidence intervals (CIs). P < .05 was accepted as significant. Statistical analysis was performed using SPSS Statistics software version 24 (IBM Corp, Armonk, NY).
The Institutional Review Board at the University of Maryland Medical Center reviewed and approved this study as exempt status as outlined in title 45 Code of Federal Regulation 46.101. Requirements for obtaining informed consent of the patient were waived as the study used data that did not contain any identifiable protected health information.
RESULTS
During the 4-year period from 2011 through 2014, a cohort of 5881 patients underwent infrarenal EVAR without hypogastric artery revascularization; 387 (6.6%) of these patients also underwent HAE as part of EVAR (HAE þ EVAR). Aside from a significantly larger proportion of male patients in the HAE þ EVAR group (88% vs 81%; P < .001), patients undergoing EVAR with or without HAE were similar in terms of demographics and comorbidities. The majority of these patients in both groups were ASA class 3. However, the HAE þ EVAR group had proportionately more ASA class 4 and class 5 patients compared with EVAR patients (P ¼ .048). Recommendation: The paper suggests that hypogastric embolization confers increased odds for development of colonic ischemia, which is associated with increased risk of death. compared with the HAE þ EVAR group (6.5% vs 5.7%; P ¼ .53) were not significantly different. On average, HAE increased operative time by 38 minutes (180 6 76 vs 142 6 68 minutes; P < .001). Patients undergoing HAE þ EVAR were more likely to require perioperative blood transfusion (17% vs 13%; P ¼ .025). Overall hospital length of stay (4 6 8.5 vs 3.3 6 5.9 days; P ¼ .001) and intensive care unit length of stay (1.2 6 3.1 vs 0.8 6 2.4 days; P ¼ .001) were significantly longer in patients requiring HAE þ EVAR. These patients were also more likely to be discharged to a skilled nursing or rehabilitation facility (12% vs 7.8%; P ¼ .008). , return trips to the operating room (4.6% vs 6.5%; P ¼ .1), and readmission rates (7.9% vs 7.5%; P ¼ .79). Renal failure requiring dialysis during the perioperative period was observed in 2.8% of patients undergoing HAE þ EVAR compared with 1% in the EVAR only group (P ¼ .001). However, the incidence of acute kidney injury (defined as a rise in serum creatinine concentration of >2 mg/dL from the preoperative value not requiring dialysis) was similar in both groups (0.5% in EVAR vs 0% with HAE þ EVAR; P ¼ .16). Pneumonia was a more frequent occurrence in patients with HAE (2.6% vs 1.3%; P ¼ .039). Thirty-day postoperative complications in patients undergoing EVAR with or without HAE are itemized in Table III. In the overall cohort, 60 patients (1%) developed ischemic colitis. On average, ischemic colitis occurred on day 5 6 7 (interquartile range, 1-4.5 days). Mortality after ischemic colitis was 35% (21/60). The incidence of ischemic colitis after HAE þ EVAR was significantly higher compared with those undergoing EVAR only (2.6% vs 0.9%; P ¼ .002). Nine of the 10 (90%) patients who developed ischemic colitis after EVAR with HAE were required to undergo surgical intervention compared with 20 of the 50 (40%) patients undergoing EVAR without HAE (P ¼ .004). The HAE þ EVAR group had a mortality rate of 4.1% compared with 2.5% in those patients undergoing EVAR only (P ¼ .044). The mortality rate for the overall cohort was 2.6% (151/5881).
To determine risk factors associated with development of statistically significant complications more frequently observed in patients undergoing HAE þ EVAR, univariate analysis was performed on each of the preoperative and intraoperative variables (Table IV) . HAE, perioperative blood transfusion, ASA class 4 or class 5, and ruptured aneurysm were associated with increased risk of 30-day mortality, ischemic colitis, renal failure requiring dialysis, and pneumonia in this cohort (P < .05). Elective admission was protective of such events. Longer than average operative time (>143 minutes for the entire cohort) was associated with increased risk of 30-day mortality, ischemic colitis, and renal failure requiring dialysis. Multivariable logistic regression was performed to determine independent preoperative and intraoperative predictors of 30-day mortality, ischemic colitis, renal failure requiring dialysis, and pneumonia (Table V) . HAE was an independent predictor of ischemic colitis (adjusted OR, 2.98; 95% CI, 1.44-6.14; P ¼ .003) and renal failure requiring dialysis (adjusted OR, 2.22; 95% CI, 1.09-4.53; P ¼ .029) on multivariable logistic regression analysis. However, HAE was not an independent predictor of mortality or pneumonia. Ruptured aneurysm and perioperative blood transfusion were independent predictors of 30-day mortality, ischemic colitis, renal failure requiring dialysis, and pneumonia. Longer than average operative time was an independent predictor of renal failure requiring dialysis in this series (adjusted OR, 2.39; 95% CI, 1.33-4.31; P < .001).
DISCUSSION
Most commonly employed endovascular techniques of aortoiliac aneurysm repair involve HAE followed by distal endograft limb extension. Endovascular techniques that maintain antegrade perfusion to the hypogastric artery, such as bell-bottom, parallel grafting, and branched endografts, have also been employed. [12] [13] [14] Multiple reports have supported the safety of unilateral intentional hypogastric artery occlusion; however, claudication remains the most prevalent complication. 15 The issue of preservation of antegrade flow as opposed to embolization of the hypogastric artery remains controversial in repair of aortoiliac aneurysm. 14, 16 Preservation of hypogastric artery flow is nonetheless paramount in prevention of ischemic complications from complex endovascular repair of thoracoabdominal aneurysms. 17 Ultee et al noted that patients undergoing concomitant procedures during EVAR have an associated higher risk of perioperative morbidity and mortality. 6 Similar to our findings, they observed longer hospital lengths of stay and more blood transfusion requirements in 228 patients undergoing concurrent HAE and EVAR. The complexity of the procedure is increased in patients undergoing HAE with EVAR as reflected by the longer operative times. Complications of ischemic colitis, renal failure requiring dialysis, and pneumonia occurred more frequently in this NSQIP series of patients with HAE. In general, patients who underwent concurrent HAE with EVAR fared worse, with proportionately more patients being discharged to a long-term care or rehabilitation facility. Ischemic colitis is a rare complication after EVAR. The incidence of ischemic colitis after open aortic aneurysm repair is well documented to be <5%. [18] [19] [20] Series examining ischemic colitis rates after EVAR often report lower rates. 7, 20, 21 In this series, 1% of patients undergoing EVAR developed ischemic colitisdin line with previously published reports. This report entails the largest series highlighting short-term outcomes after HAE. 16, 20 The impact of HAE on patients undergoing EVAR and subsequent risk for development of ischemic colitis remain poorly understood. In our series, 2.6% of patients undergoing HAE with EVAR developed ischemic colitis compared with 0.9% of patients who did not have hypogastric artery occlusion. Similarly, Becquemin et al noted a 3.6% rate of ischemic colitis with HAE compared with 0.7% without HAE in 492 patients treated with EVAR (P ¼ .046). 20 Other investigators have not found an associated increase in risk of ischemic colitis with HAE in EVAR patients. [21] [22] [23] However, these studies are singlecenter experiences with smaller cohorts of patients, which would make capturing a rare complication event difficult.
Multiple causes have been proposed with regard to risk of occurrence of ischemic colitis after EVAR. Atheroembolization, occlusion of the inferior mesenteric artery or hypogastric artery, and nonocclusive ischemia from a low-flow state have been proposed as possible mechanisms. 19, 21, 24 It is difficult to assess the exact mechanism by which HAE contributes to ischemic colitis in this large database series as few anatomic data are available within the NSQIP. Perhaps exacerbation of a low-flow state worsened by lack of collateral flow is a more likely scenario in this series as ruptured aneurysm and blood transfusion in addition to HAE were independent predictors of ischemic colitis. The severity of an ischemic colitis event may be inferred from the number of patients requiring operative intervention. Notably, nearly all patients who developed ischemic colitis after HAE required operative treatment compared with less than half of the patients who did not have HAE.
The administration of a large dose of contrast material and development of contrast-induced nephropathy with concurrent HAE and EVAR remains a concern. 24 As such, HAE is often performed as a staged procedure in anticipation for EVAR. Acute kidney injury is reported in up to 19% and 23% of elective and ruptured EVARs, respectively. 25 The administration of a large volume of contrast material and intravascular volume depletion significantly increase risk of renal failure. 26 We observed a higher incidence of postoperative dialysis in patients undergoing concurrent HAE with EVAR. In addition to HAE, ruptured aneurysm, perioperative blood transfusions, longer operative times, and higher ASA physical status classification were independent preoperative and intraoperative factors contributing to postoperative renal failure requiring dialysis. Although the mortality rate with HAE was significantly higher, HAE itself was not an independent predictor of death. The observed increase in mortality is likely attributed to increased risk of associated complications that develop as a result of HAE. The 35% mortality rate of this series is in the lower range of mortality rates reported in the literature. Mortality rates of up to 60% have been reported in the literature with ischemic colitis for open and endovascular aortic aneurysm repair. 20 There are several limitations to this study. Measured outcome variables in this study are limited by definitions of the ACS NSQIP database. We are unable to determine whether HAE at the time of EVAR was carried out unilaterally or bilaterally. We are also unable to determine if any of the patients underwent staged HAE before EVAR. Minimal anatomic data are collected in the ACS NSQIP database. As a result, presence or absence of occlusive disease in other vascular beds (eg, patency of the contralateral hypogastric artery) or adequacy of collateralization cannot be established. Furthermore, whether HAE was performed for treatment of an aneurysmal hypogastric artery or as a means of achieving a distal seal in the external iliac artery because of an aneurysmal common iliac artery remains unknown.
CONCLUSIONS
Overall, patients who underwent concurrent HAE with EVAR in this study experienced longer and more complicated hospital stays, with more patients requiring rehabilitation on discharge. Ischemic colitis is a rare complication of EVAR but was observed at significantly higher rates and with increased severity in the HAE group. As such, HAE with EVAR in this study was not a benign procedure. Efforts should be made to ensure preservation of hypogastric artery perfusion in patients undergoing EVAR requiring the external iliac artery as the distal landing zone. 
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